1.
Kim JH, Lee W, Kim TN, Nam JK, Kim TH, Lee KS. Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. CUAJ [Internet]. 2017 Nov. 23 [cited 2024 Apr. 26];12(1):E15-20. Available from: https://cuaj.ca/index.php/journal/article/view/4644